ACS,ACT.CO.SER.INH.EO-,50 | 25.570 / -0.66% |
Date/Time | 05/24 / 08:07 |
Chg. / Chg.(%) | -0.170 / -0.66% |
Bid | 25.670 / 2000 |
Ask | 25.730 / 2000 |
Open | 25.570 |
Previous Close | 25.740 |
High | 25.570 |
Low | 25.570 |
Volume [EUR] | 0.000 |
Volume [Units] | 0 |
Price fixings | 1 |
ISIN | ES0167050915 |
Security | OCI1 |
Exchange | München |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Madrid | 25.7000 | ![]() |
137,744 |
Cboe Europe .. | 25.70 | ![]() |
50,320 |
Turquoise | 25.70 | ![]() |
6,897 |
London Inter.. | 25.69 | ![]() |
711 |
Frankfurt | 25.8400 | ![]() |
60 |
TradeGate | 25.510 | ![]() |
60 |
gettex | 25.590 | ![]() |
60 |
Vienna Globa.. | 25.67 | ![]() |
0 |
München | 25.570 | ![]() |
0 |
Berlin | 25.500 | ![]() |
0 |
Düsseldorf | 25.410 | ![]() |
0 |
Hannover | 25.390 | ![]() |
0 |
Quotrix | 25.4700 | ![]() |
|
Lang & Schwa.. | 25.690 | ![]() |
|
Stuttgart | 25.040 | ![]() |
|
Cboe Europe .. | 25.47 | 412 | |
Nasdaq Other.. | 27.0000 | 204 | |
Cboe Europe .. | 24.17 | 67 | |
EUREX | Options |
News
- ProMIS Neurosciences Presents Preclinical Results of its Experimental Alzheimer’s Vaccine at the 2022 International AD/PDTM Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
03/22/2022 / 12:00 - GlobeNewswire - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Volt Information Sciences, Inc (NYSE American - VOLT), Whiting Petroleum Corporation (NYSE - WLL), Intricon Corporation (Nasdaq - IIN)
03/14/2022 / 18:03 - GlobeNewswire - VOLT Alert: Monsey Firm of Wohl & Fruchter LLP Investigating Sale of Volt Information Sciences to Vega Consulting
03/14/2022 / 14:35 - GlobeNewswire - Advantest Opens Registration for International VOICE 2022 Developer Conference, May 17-18
03/08/2022 / 09:05 - GlobeNewswire - New to The Street TV Announces its Line-ups Airing on the Fox Business Network, Episode #308, Tonight Monday, February 21, 2022, 10:30 PM PT and Episode #309, Tomorrow Night, Tuesday, February 22, 2022, 10:30 PM PT
02/21/2022 / 16:45 - GlobeNewswire